Underlying host immune dysregulation in cancer patients developing immune-related adverse events. Gerber, D. E., Khan, S., Luo, X., Khan, S. A., Fattah, F., Saltarski, J., Gloria-McCutchen, Y., Park, J., Xie, Y., Li, Q., Wakeland, E. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.3030

View details for Web of Science ID 000442916001403